(Q46753462)

24 December 2017

title

Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats (English)

1 reference

24 December 2017

author name string

Fu-ming Shen

1

1 reference

24 December 2017

He-hui Xie

2

1 reference

24 December 2017

Gang Ling

3

1 reference

24 December 2017

Li-ping Xu

4

1 reference

24 December 2017

Ding-feng Su

5

1 reference

24 December 2017

publication date

1 November 2005

1 reference

24 December 2017

Acta Pharmacologica Sinica

published in

1 reference

24 December 2017

volume

26

1 reference

24 December 2017

issue

11

1 reference

24 December 2017

page(s)

1303-1308

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2005.00185.x

exact match

0 references

cites work

Blood pressure and heart rate variabilities in normotensive and hypertensive human beings.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Blood pressure variability and organ damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with long-term hydrochlorothiazide mixture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Current recommendations for initial therapy in hypertension: are they still valid? Introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

The role of combination therapy in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Reduction of blood pressure variability: a new strategy for the treatment of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

Comparison of the effects of an ACE inhibitor and alphabeta blocker on the progression of renal failure with left ventricular hypertrophy: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00185.X

10.1111/J.1745-7254.2005.00185.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

Dimensions Publication ID

1019547897

0 references

1 reference

24 December 2017